Welcome to LookChem.com Sign In|Join Free

CAS

  • or

218449-63-9

Post Buying Request

218449-63-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

218449-63-9 Usage

General Description

[2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER is a chemical compound that belongs to the class of carbamic acid esters. It is a derivative of 2-hydroxyethyl carbamic acid and 1,1-dimethylethyl alcohol, and it contains a difluorophenyl group. [2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER is commonly used in the pharmaceutical industry as a potential drug candidate for the treatment of various diseases. It may also have applications in the field of organic chemistry as a reagent or intermediate in the synthesis of other compounds. Overall, [2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER is a versatile chemical with potential uses in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 218449-63-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,4,4 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 218449-63:
(8*2)+(7*1)+(6*8)+(5*4)+(4*4)+(3*9)+(2*6)+(1*3)=149
149 % 10 = 9
So 218449-63-9 is a valid CAS Registry Number.

218449-63-9Downstream Products

218449-63-9Relevant articles and documents

Oxazolidinones as alpha 1A receptor antagonists

-

, (2008/06/13)

This invention is directed to oxazolidinone compounds which are selective antagonists for human alpha 1A receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia and for the treatment of any disease where the antagonism of the alpha 1A receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 218449-63-9